NCT00520533 2022-10-12
Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma
Ludwig Institute for Cancer Research
Phase 1 Terminated
Clinical Trials
5 trialsNCT00087022 2018-11-27
ARISER
Heidelberg Pharma AG
Phase 3 Completed
NCT01762592 2017-12-22
REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
Heidelberg Pharma AG
Phase 3 Withdrawn
NCT02883153 2017-06-19
Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma
Radboud University Medical Center
Phase 2/3 Completed
NCT00602862 2013-12-02
Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250
Radboud University Medical Center
Phase NA Completed